Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
United States Innovative Technology (USIT) is a private investment fund launched around 2022 to invest $3–5 billion in growth and early‑stage companies developing critical technologies in areas such as defense, artificial intelligence, cyber, satellites, biotechnology, quantum computing, and space, with a national security and US competitiveness focus.[2][4]
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on United States Innovative Technology.